Toby L Nelson
Overview
Explore the profile of Toby L Nelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Conn B, Lieberman J, Chatman P, Cotton K, Essandoh M, Ebqaai M, et al.
Front Microbiol
. 2024 Jan;
14:1339303.
PMID: 38293553
is an opportunistic fungal pathogen that causes meningitis in >152,000 immunocompromised individuals annually, leading to 112,000 yearly deaths. The four classes of existing antifungal agents target plasma membrane sterols (ergosterol),...
2.
Adhikari S, Essandoh M, Starr W, Sah P, La Force C, Eleshy R, et al.
ACS Appl Bio Mater
. 2022 Feb;
5(2):545-551.
PMID: 35113537
The reliance on antibiotics and antimicrobials to treat bacterial infectious diseases is threatened by the emergence of antibiotic resistance and multi-drug-resistant organisms, thus having the potential to greatly impact human...
3.
Richter B, Mace Z, Hays M, Adhikari S, Pham H, Sclabassi R, et al.
Sensors (Basel)
. 2021 Nov;
21(22).
PMID: 34833660
Advancements in electrode technologies to both stimulate and record the central nervous system's electrical activities are enabling significant improvements in both the understanding and treatment of different neurological diseases. However,...
4.
Covalently Loaded Naloxone Nanoparticles as a Long-Acting Medical Countermeasure to Opioid Poisoning
Kassick A, Wu M, Luengas D, Ebqaai M, Tharika Nirmani L, Tomycz N, et al.
ACS Pharmacol Transl Sci
. 2021 Oct;
4(5):1654-1664.
PMID: 34661081
The mu opioid receptor antagonist naloxone has been a vital, long-standing countermeasure in the ongoing battle against opioid use disorders (OUD) and toxicity. However, due to its distinctive short elimination...
5.
Minus M, Moor S, Pary F, Nirmani L, Chwatko M, Okeke B, et al.
Org Lett
. 2021 Mar;
23(8):2873-2877.
PMID: 33784461
Typically, Suzuki couplings used in polymerizations are performed at raised temperatures in inert atmospheres. As a result, the synthesis of aromatic materials that utilize this chemistry often demands expensive and...
6.
Urbina-Blanco C, Jilani S, Speight I, Bojdys M, Friscic T, Stoddart J, et al.
Angew Chem Int Ed Engl
. 2021 Jan;
59(42):18306-18310.
PMID: 33448562
Valuing diversity leads to scientific excellence, the progress of science and most importantly, it is simply the right thing to do. We can value diversity not only in words, but...
7.
Pary F, Nelson L, Nelson T
ACS Cent Sci
. 2020 Dec;
6(12):2133-2135.
PMID: 33376776
No abstract available.
8.
Urbina-Blanco C, Jilani S, Speight I, Bojdys M, Friscic T, Stoddart J, et al.
Nat Chem
. 2020 Aug;
12(9):773-776.
PMID: 32807887
No abstract available.
9.
Urbina-Blanco C, Jilani S, Speight I, Bojdys M, Friscic T, Stoddart J, et al.
J Am Chem Soc
. 2020 Aug;
142(34):14393-14396.
PMID: 32803980
No abstract available.
10.
Kassick A, Allen H, Yerneni S, Pary F, Kovaliov M, Cheng C, et al.
ACS Appl Bio Mater
. 2019 Sep;
2(8):3418-3428.
PMID: 31497753
The opioid epidemic currently plaguing the United States has been exacerbated by an alarming rise in fatal overdoses as a result of the proliferated abuse of synthetic mu opioid receptor...